These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Newer antidepressants for the treatment of depression in adults. Hatcher S; Arroll B BMJ; 2012 Jan; 344():d8300. PubMed ID: 22262785 [No Abstract] [Full Text] [Related]
3. One foot on the bandwagon? Pies R J Clin Psychopharmacol; 1995 Oct; 15(5):303-5. PubMed ID: 8830060 [No Abstract] [Full Text] [Related]
4. Treatment of major depressive disorder in children and adolescents. Ramchandani P BMJ; 2004 Jan; 328(7430):3-4. PubMed ID: 14703522 [No Abstract] [Full Text] [Related]
5. Pharmacotherapeutic approaches to treatment-resistant depression. St John D JAAPA; 2003 Mar; 16(3):32-4, 37-8, 40 passim. PubMed ID: 14968524 [No Abstract] [Full Text] [Related]
6. Serotonergic mechanisms and the new antidepressants. Stahl SM Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642 [No Abstract] [Full Text] [Related]
7. The management of depression: the implications for managed care--roundtable discussion: Part 3. Vodoor M; Southwell YP; Grubin M; Wert S; Kang-Cipolla L; Denes A; Evans S; Mason J; Zarr M; Osborn L; Kenney J; Hunkeler E; Waugh W; Bull S Manag Care Interface; 2000; Suppl B():26-32. PubMed ID: 11183022 [TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of antidepressive agents: a systematic critique of experimental and observational studies. Barbui C; Percudani M; Hotopf M J Clin Psychopharmacol; 2003 Apr; 23(2):145-54. PubMed ID: 12640216 [TBL] [Abstract][Full Text] [Related]
9. Antidepressants and side effects. Carter G Aust N Z J Psychiatry; 1995 Jun; 29(2):337. PubMed ID: 7487802 [No Abstract] [Full Text] [Related]
10. The management of depression: the implications for managed care--roundtable discussion: Part 2. Arikian S; Casciano J; Kang-Cipolla L; Vodoor M; Grubin M; Clark D; Waugh W; Kelsey J; Osborn LW Manag Care Interface; 2000; Suppl B():19-25, 32. PubMed ID: 11183021 [TBL] [Abstract][Full Text] [Related]
12. Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder. Armstrong EP; Skrepnek GH; Haim Erder M Curr Med Res Opin; 2007 Feb; 23(2):251-8. PubMed ID: 17288678 [TBL] [Abstract][Full Text] [Related]
13. Cost-effective treatment of depression with selective serotonin reuptake inhibitors. Panzarino PJ; Nash DB Am J Manag Care; 2001 Feb; 7(2):173-84. PubMed ID: 11216334 [TBL] [Abstract][Full Text] [Related]
14. Lack of adverse reaction when switching SSRIs to NASSRIs in polymedicated depressed inpatients. Haffen E; Vandel P; Regina W; Vandel S Therapie; 1999; 54(2):267-9. PubMed ID: 10394269 [No Abstract] [Full Text] [Related]
15. [Antidepressive effectiveness and good tolerance]. Nervenarzt; 1997 Feb; 68(2 Suppl):5-7. PubMed ID: 9173321 [No Abstract] [Full Text] [Related]
16. Finding the right antidepressant medication. Johns Hopkins Med Lett Health After 50; 2000 Oct; 12(8):6-7. PubMed ID: 11002753 [No Abstract] [Full Text] [Related]
17. Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy. Mills JL N Engl J Med; 2006 Feb; 354(6):636-8. PubMed ID: 16467553 [No Abstract] [Full Text] [Related]
18. The use of serotonin reuptake inhibitors in pregnancy. Malek-Ahmadi P Can J Psychiatry; 2000 Dec; 45(10):939-40. PubMed ID: 11190370 [No Abstract] [Full Text] [Related]